|
Tocris
fgf receptor fgfr inhibitor su5402 ![]() Fgf Receptor Fgfr Inhibitor Su5402, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/fgf receptor fgfr inhibitor su5402/product/Tocris Average 95 stars, based on 1 article reviews
fgf receptor fgfr inhibitor su5402 - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
|
Tocris
su 5402 ![]() Su 5402, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/su 5402/product/Tocris Average 95 stars, based on 1 article reviews
su 5402 - by Bioz Stars,
2026-06
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
fgf ![]() Fgf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/fgf/product/Santa Cruz Biotechnology Average 93 stars, based on 1 article reviews
fgf - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
SU 5402 is an inhibitor of the tyrosine kinase domains of VEGFR2 FGFR1 and PDGFRβ ICs 0 02 0 03 and 0 51 µM respectively It is much less effective against other receptor tyrosine kinases
|
Buy from Supplier |
|
SU-5402 2-Hydroxyethyl Ester is an SU 5402 production intermediate
|
Buy from Supplier |
|
Product Describtion:SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGFRβ, respectively.
|
Buy from Supplier |
|
SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGFRβ, respectively.
|
Buy from Supplier |
Image Search Results
Journal: International Journal of Molecular Sciences
Article Title: Derivation of Porcine Extra-Embryonic Endoderm Cell Lines Reveals Distinct Signaling Pathway and Multipotency States
doi: 10.3390/ijms222312918
Figure Lengend Snippet: Signaling dependence analysis of pXEN cells. ( A ) The morphology and JC1 staining of pXEN cells cultured in LCDM, LCDM+10μm SD1008, LCDM+10μm SU5402 and LCDM+10μm SB431542. ( B ) Quantitative RT-PCR analysis of FGF, TGFβ and LIF signaling related genes in pXEN cells, porcine nESCs and porcine embryo fibroblasts (PEF). Relative expression reflected as a fold difference in pXEN cells and porcine nESCs compared to PEF, PEF = 1. Data are depicted as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 versus Control ( t -test). ( C ) The morphology of pXEN cells cultured in LCDM and LCDM supplemented with 1, 5 and 10μM concentration of PD0325901. ( D ) Western blotting analysis of the phosphorylation status of ERK, STAT3 andSMAD2/3, and the expression of ERK, STAT3 andSMAD2/3 in pXEN cells and porcine nESCs. ( E ) The quantification of proteins after Western blotting. Scale bar, 100μm.
Article Snippet: The cells were cultured in medium supplemented with or without the JAK inhibitor SD1008 (Tocris), the
Techniques: Staining, Cell Culture, Quantitative RT-PCR, Expressing, Control, Concentration Assay, Western Blot, Phospho-proteomics
Journal: PLoS ONE
Article Title: Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts
doi: 10.1371/journal.pone.0182716
Figure Lengend Snippet: (A) MG-63 cells were cultured in OIM supplemented with DMSO (0.1% v/v) and were pretreated with various concentrations of SU5402 (0.1–1 μM) or SB505124 (0.5–1 μM) for 1 h, followed by treatment with 400 μg/mL CME. After 9 days, mineralization was determined by performing Alizarin red S staining. Alizarin red S stain was extracted using 10% cetylpyridinium chloride, and absorbance was measured at 570 nm. (B) For the calcium assay, the cells were pretreated with DMSO (0.1% v/v) and various concentrations of SU5402 (0.1–1 μM) or SB505124 (0.5–1 μM) alone or their combination for 1 h, followed by treatment with 200 μμg/mL CME. Calcium assay was performed after 9 days. (C) Expression of genes encoding ALP and IBSP was determined on day 4 by performing quantitative real-time RT-PCR under the experimental condition described in (A): SU5402: FGF specific inhibitor, SB505124: TGFβ-1 specific inhibitor, SU+SB: SU5402+SB505124. Data are presented as the mean ± SD of multiple repeated experiments; * p < 0.05, ** p < 0.01, and # p < 0.001 versus only CME, indicate statistical significance.
Article Snippet: Recombinant human bFGF, TGFβ-1, EGF, and BMP2 were purchased from Peprotech (Rocky Hill, NJ, USA), and inhibitors of
Techniques: Cell Culture, Staining, Calcium Assay, Expressing, Quantitative RT-PCR